Saroja Pharma Industries India Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

28.60 -1.35 (-4.51%)Updated : 17 Jul 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	66.54	51.05	38.21	47.54
Other Net	0.11	-0.01	0.02	-0.17
Diluted Weighted Average Shares	0.40	0.40	0.35	0.40
Depreciation/ Amortization	0.11	0.11	0.09	0.07
Operating Income	3.59	2.67	2.46	2.65
Net Income	1.62	1.03	0.88	1.06
Income Availableto Com Excl Extra Ord	1.62	1.03	0.88	1.06
Net Income Before Taxes	2.24	1.45	1.21	1.49
Other Operating Expenses Total	1.41	1.09	1.01	0.81
Net Income After Taxes	1.62	1.03	0.88	1.06
Income Availableto Com Incl Extra Ord	1.62	1.03	0.88	1.06
Costof Revenue Total	63.83	48.58	35.64	45.30
Gross Profit	6.30	5.15	5.03	4.90
Interest Inc( Exp) Net- Non- Op Total	-1.46	-1.22	-1.28	-0.99
Diluted Net Income	1.62	1.03	0.88	1.06
Provisionfor Income Taxes	0.62	0.42	0.33	0.43
period Type	-	-	-	-
Net Income Before Extra Items	1.62	1.03	0.88	1.06
Total Revenue	70.13	53.73	40.67	50.19
period Length	12.00	12.00	12.00	12.00
Revenue	70.13	53.73	40.67	50.19
Selling/ General/ Admin Expenses Total	1.20	1.28	1.46	1.37
Diluted Normalized EPS	4.02	2.57	2.49	2.64
Diluted EPS Excluding Extra Ord Items	4.02	2.57	2.49	2.64
DPS- Common Stock Primary Issue	-	-	-	0.00